Sironax Named to Fierce Biotech’s 2026 Fierce 15 List of Most Innovative Private Biotechs

Congratulations to Sironax on being named to Fierce Biotech's 2026 Fierce 15 list of the most innovative and promising private biotechnology companies.

The recognition reflects the company's approach to challenging therapeutic targets and the potential of its science.

Read the full announcement

Next
Next

Tempus Expands Collaboration with Moderna and Merck to Support Individualized Cancer Therapy Delivery